Dawn Svoronos - May 16, 2022 Form 4 Insider Report for Adverum Biotechnologies, Inc. (ADVM)

Role
Director
Signature
Dawn Svoronos, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
ADVM
Transactions as of
May 16, 2022
Transactions value $
$25,578
Form type
4
Date filed
5/18/2022, 04:43 PM
Previous filing
Jan 11, 2022
Next filing
Jun 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADVM Common Stock Purchase $25.6K +30K +150% $0.85 50K May 16, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $0.8402 to $0.8538. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.